stella
beta
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC — Stella
Recruiting
Back to Nasopharangeal Cancer trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(5 sites)
China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong
Hunan Cancer Hospital, Changsha
Fujian Cancer Hospital, Fuzhou
Zhejiang Cancer Hospital, Hangzhou
Guangxi Medical University Cancer Hospital, Nanning
View full record on ClinicalTrials.gov